These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23446231)

  • 1. LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice.
    Archer A; Stolarczyk E; Doria ML; Helguero L; Domingues R; Howard JK; Mode A; Korach-André M; Gustafsson JÅ
    J Lipid Res; 2013 May; 54(5):1300-11. PubMed ID: 23446231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
    Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.
    Kiss E; Popovic Z; Bedke J; Wang S; Bonrouhi M; Gretz N; Stettner P; Teupser D; Thiery J; Porubsky S; Adams J; Gröne HJ
    Am J Pathol; 2011 Jul; 179(1):92-103. PubMed ID: 21703396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver X receptor (LXR) regulates human adipocyte lipolysis.
    Stenson BM; Rydén M; Venteclef N; Dahlman I; Pettersson AM; Mairal A; Aström G; Blomqvist L; Wang V; Jocken JW; Clément K; Langin D; Arner P; Laurencikiene J
    J Biol Chem; 2011 Jan; 286(1):370-9. PubMed ID: 21030586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
    Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels.
    van der Hoorn J; Lindén D; Lindahl U; Bekkers M; Voskuilen M; Nilsson R; Oscarsson J; Lindstedt E; Princen H
    Br J Pharmacol; 2011 Apr; 162(7):1553-63. PubMed ID: 21175581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity.
    Korach-André M; Archer A; Barros RP; Parini P; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):403-8. PubMed ID: 21173252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation.
    Wang YY; Dahle MK; Agren J; Myhre AE; Reinholt FP; Foster SJ; Collins JL; Thiemermann C; Aasen AO; Wang JE
    Shock; 2006 Feb; 25(2):141-6. PubMed ID: 16525352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.
    Zhang XQ; Even-Or O; Xu X; van Rosmalen M; Lim L; Gadde S; Farokhzad OC; Fisher EA
    Adv Healthc Mater; 2015 Jan; 4(2):228-36. PubMed ID: 25156796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.
    Lee YS; Park MS; Choung JS; Kim SS; Oh HH; Choi CS; Ha SY; Kang Y; Kim Y; Jun HS
    Diabetologia; 2012 Sep; 55(9):2456-68. PubMed ID: 22722451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
    Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages.
    Zhang R; Dong Y; Liu Y; Moezzi D; Ghorbani S; Mirzaei R; Lozinski BM; Dunn JF; Yong VW; Xue M
    Stroke Vasc Neurol; 2023 Dec; 8(6):486-502. PubMed ID: 37137522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.
    Russell ST; Tisdale MJ
    Int J Obes (Lond); 2011 Mar; 35(3):345-54. PubMed ID: 20697416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice.
    Schoiswohl G; Stefanovic-Racic M; Menke MN; Wills RC; Surlow BA; Basantani MK; Sitnick MT; Cai L; Yazbeck CF; Stolz DB; Pulinilkunnil T; O'Doherty RM; Kershaw EE
    Endocrinology; 2015 Oct; 156(10):3610-24. PubMed ID: 26196542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
    Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
    Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance.
    Wang Q; Dong Z; Liu X; Song X; Song Q; Shang Q; Jiang Y; Guo C; Zhang L
    Diabetes; 2013 Dec; 62(12):4132-43. PubMed ID: 23990362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK.
    Gaidhu MP; Anthony NM; Patel P; Hawke TJ; Ceddia RB
    Am J Physiol Cell Physiol; 2010 Apr; 298(4):C961-71. PubMed ID: 20107043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
    Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.